Indivior PLC (OTCMKTS:INVVY – Get Free Report) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $21.85 and traded as low as $21.64. Indivior shares last traded at $21.8455, with a volume of 8,100 shares.
Indivior Stock Down 1.8%
The stock has a market capitalization of $3.01 billion, a P/E ratio of 20.81 and a beta of 0.35. The business’s 50 day simple moving average is $21.85 and its two-hundred day simple moving average is $21.85.
Indivior Company Profile
Indivior PLC is a specialty pharmaceutical company focused on developing and commercializing treatments for addiction and related disorders. The company’s core business centers on addressing opioid use disorder through a portfolio of branded pharmaceuticals and delivery systems designed to support long-term recovery. Indivior’s therapies are aimed at improving patient outcomes by reducing withdrawal symptoms and lowering the risk of relapse.
The company’s flagship product, Suboxone®, is a buprenorphine-naloxone sublingual film approved for the treatment of opioid dependence.
Featured Stories
- Five stocks we like better than Indivior
- Microsoft’s Maia 300 Chip Targets NVIDIA’s AI Dominance
- 3 Unexpected ETFs Crushing the Market This Summer
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
